Desmoid tumor initially unresectable – About two cases

Document Type : Case Report


1 Department of General Surgery, Hospital Universitari Germans Trias i Pujol, Barcelona

2 Department of Oncology, Hospital Germans Trias i Pujol, Barcelona


Desmoid tumor, also called aggressive fibromatosis, is a rare fibroblastic proliferation of connective tissue and
skeletal muscle aponeurosis. The aetiology of desmoid tumours is poorly understood, but they have been related
with oestrogen stimuli, previous trauma, surgical interventions and pregnancy. Although it is characterized by not
having potential for metastasize or differentiate, it is a non-encapsulated lesion, with an infiltrative growth and
unpredictable behaviour. In this way, it could have either an aggressive pattern, when compared with other low
degree malignancy sarcomas, or a very indolent one, even with spontaneous regression. Therapeutic options in
desmoid tumours have been changing over these last years, as surgery upfront in asymptomatic patients has
been superseded by active surveillance. However, treatment has to be individualized in some specific scenarios
such as intra-abdominal lesions. We present two cases of patients diagnosed with an intra-abdominal desmoid
tumour with threatening behaviour, the treatment approach and final resolution.


Shiu M, Weinstein L, Hajdu S, Brennan M. Malignant soft-tissue tumors of the anterior abdominal wall. The American Journal of Surgery 1989; 158: 446-451.
2. Middleton SB, Phillips RK. Surgery for large intra-abdominal desmoid tumors. Report of four cases. Diseases of the Colon & Rectum. 2000;43: 1759-62.
3. Patel SR, Evans HL, Benjamín RS. Combination chemotherapy in adult desmoid tumors. Cancer 1993; 72: 3244 - 3247.
4. Zaharia M, Moscol A, Misad O, Cáceres E, Barriga O. Valor de la radioterapia en el tratamiento de la fibromatosis agresiva. Acta Cancerológica (Perú) 1992; 22: 11-14.
5. Nuyttens JJ, Rust PF, Thomas CR Jr, Turrisi AT 3rd. Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles. Cancer. 2000;88:1517-23.
6. Bertario L, Russo A. Genotype and phenotype factors as determinants of desmoid tumors in patients with familial adenomatous polyposis. The International Journal of Cancer. 2001 Mar 20;95(2):102-7.
7. Bernd Kasper, Philipp Ströbel, Peter Hohenbergera. Desmoid Tumors: Clinical Features and Treatment Options for Advanced Disease. Oncologist. 2011 May; 16(5): 682–693.
8. Smith AJ, Lewis JJ, Merchant NB, Leung DM, Woodruff JM, Brennan MF. Surgical management of intraabdominal desmoid tumors. British Journal of Surgery. 2000;87:608-13.
9. B. Kasper1, C. Baumgarten. An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma Patients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Annals of Oncology 28: 2399–2408, 2017
10. Burke AP, Sobin LH, Shekitka DM, et al: Intraabdominal fibromatosis: a pathologic analysis of 130 tumors with comparison of clinical subgroups. American Journal of Surgical Pathology 1990; 14: 335-41.